May, 2018 | The Wall Street Analyzer

Latest News

[ September 21, 2021 ] Golden Independence Intersects 1.71 g/t Gold and 6.0 g/t Silver over 70 Feet at Independence Project News Feed
[ September 14, 2021 ] Successful Trenching Programme in the Kobada Est Target Confirms Similar Structural Mineralization to Kobada Main Shear News Feed
[ September 9, 2021 ] Goldshore Resources Receives Initial Magnetics Images from Geotech VTEM System Survey on the Moss Lake Gold Project News Feed
[ September 7, 2021 ] Citius Pharmaceuticals Acquires Dr. Reddy’s Laboratories’ License for Late-Phase 3 Oncology Immunotherapy (E7777) for the Treatment of Cutaneous T-Cell Lymphoma and other Cancer Indications News Feed
[ September 2, 2021 ] African Gold Group Delivers a 44% Increase in Measured and Indicated Mineral Resource for the Kobada Gold Project to 1.71 Million Ounces News Feed
[ August 27, 2021 ] Pro-Dex, Inc. Announces Fiscal 2021 Fourth Quarter and Full-Year Results News Feed
[ August 27, 2021 ] BluMetric Announces Strong Financial Results for Q3 2021 News Feed

Pyxis Tankers (NASDAQ: PXS) Management Interview

May 30, 2018 The Wall Street Analyzer Comments Off

Management Interview […]

iAnthus Capital Holdings (OTCQB: ITHUF) (CSE: IAN) CEO: Hadley Ford

May 30, 2018 The Wall Street Analyzer Comments Off

Interview with Hadley Ford, CEO […]

Victoria Gold Provides Eagle Development Update, Yukon Territory

May 25, 2018 The Wall Street Analyzer Comments Off

TORONTO, May 24, 2018 (GLOBE NEWSWIRE) — Victoria Gold Corp. (TSX-V:VIT) “Victoria” or the “Company” is pleased to provide a construction update for the Eagle Gold Mine Project (the “Project”), Yukon Canada. Full construction commenced […]

Acerus Pharmaceuticals Corporation (TSX: ASP) CEO: Ed Gudaitis

May 23, 2018 The Wall Street Analyzer Comments Off

Founded in 2008, Acerus has quickly grown into a fully integrated company with expertise in all stages of the pharmaceutical product lifecycle, and focus in the therapeutic areas of Men’s Health (Urology) and Women’s Health (Hormone Replacement Therapy, Female Sexual Dysfunction). […]

Aerkomm Inc. (OTCQX: AKOM) CEO Interview

May 23, 2018 The Wall Street Analyzer Comments Off

Interview with Jeffrey Wun, CEO […]

Well Leveraged: VBI Vaccines Outlines Clinical Trial Progress

May 23, 2018 The Wall Street Analyzer Comments Off

NEW YORK, May 22, 2018 (GLOBE NEWSWIRE) — Jeff Baxter, President and CEO of VBI Vaccines Inc. (NASDAQ:VBIV), a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, took time to update WSA’s investor […]